Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis

NCT ID: NCT00119990

Last Updated: 2008-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-01-31

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During peritoneal dialysis, water is removed from the body. This sometimes occurs at rates of up to 500 ml/h. During shifts with dialysate with high glucose content, an increase in blood pressure has been described. The effect upon central hemodynamics is unknown. The researchers are investigating the effects of low and high glucose dialysate and icodextrin on cardiac output, stroke volume, pulse rate and blood pressure. The researchers have hypothesized that the effects seen are induced by vasopressin.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peritoneal Dialysis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

vasopressin icodextrin cardiac output

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Icodextrin (dialysate)

2 liter of extraneal are given with one fill for 4 hours.

Intervention Type DRUG

Physioneal (dialysate) 1.36% and 2.27%

2 liter of Physioneal of 1.36% or 3.86% are given with one fill for 4 hours one two different days.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Peritoneal dialysis patients

Exclusion Criteria

* Insulin dependent diabetes mellitus
* AV-fistula, cardial arrhythmia persistence, or severe cardiac and lung disease
* Recent infectious disease
* Severe psychiatric disease
* Hypersensitivity to icodextrin
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Departement of Renal Medicine, Aarhus Universityhospital, Skejb

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Per Ivarsen

Role: PRINCIPAL_INVESTIGATOR

Department of Renal Medicine C, Skejby Hospital, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Deparment of Renal Medicine, Skejby Hospital

Aarhus, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Boon D, Bos WJ, van Montfrans GA, Krediet RT. Acute effects of peritoneal dialysis on hemodynamics. Perit Dial Int. 2001 Mar-Apr;21(2):166-71.

Reference Type BACKGROUND
PMID: 11330561 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AA20050009

Identifier Type: -

Identifier Source: org_study_id